We’re a team on amission
Vision 2020: Empowering Our Future is a strategic initiative designed to deepen and expand our pipeline over five years. We plan to advance a portfolio of novel muscle activators toward late-stage development and commercialization to address urgent unmet needs of people living with conditions characterized by impaired muscle function who have few, if any, treatment options.
The key components of Vision 2020: Empowering Our Future are:
- Progress proprietary research programs focused on muscle contractility, growth and energetics into development under new collaborations;
- Advance next-generation skeletal and cardiac muscle activator compounds into clinical development by leveraging existing research collaborations;
- Conduct late-stage clinical development of novel, first-in-class muscle activators for the potential treatment of amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), heart failure and other diseases impacting muscle function;
- Collaborate with patient communities to support the urgent development of new medicines for diseases of impaired muscle function with pressing unmet medical needs; and
- Mature company operations to enable development, registration and commercialization of muscle biology drug candidates across North America and Europe.